Cytek Biosciences, Inc.

NASDAQ:CTKB

Medical - Devices

Healthcare
$5.92 -2.64%

-$0.11 today

Market cap
$774.24M
Beta
1.19
P/E (TTM)
-6.7
EPS (TTM)
-$0.57
52W Low $2.90High $6.18

Volume 1.05M

Average 0.88M

CTKB Other Investing Activities

Investing cash flows not reported separately.

Cytek Biosciences, Inc.NASDAQ: CTKB

Other Investing Activities · Q1 FY2026 · quarter ended Mar 2026

Other investing activities turns negative

Q1 FY2026 other investing activities was -$27K, compared with $31K a year earlier. Trailing-twelve-month other investing activities was $87K. Over 3 fiscal years it compounded at -3.7% a year.

Context

  • Other investing activities amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
  • Other investing activities increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly other investing activities holds near -$27K or moves back toward the trailing-twelve-month quarterly average of $21.75K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$27K-116.7% QoQ
Last fiscal yearDec 2025
-$107K-227.4% YoY
LTMMar 2026
$87K+102.3% YoY
Other Investing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-187.1%——
1 year-227.4%——
3-year CAGR-3.7%——
5-year CAGR——
10-year CAGR——

Other Investing Activities history

USD · from the cash flow

Latest · FY2025
(107K) USD
Year-over-year change
-227.4%

Other Investing Activities vs competitors

How CTKB compares with its peers on the latest reported figures

  • CTKB's LTM Mar 2026 other investing activities of $87K is the smallest of the 6 companies compared; the peer median is $1M.
  • Its year-over-year change of +102.3% is the 3rd highest of 6, against a peer median of -39.0%.
  • Other investing activities amounts to 0.0% of revenue for CTKB, versus a peer median of 1.2%.
CTKB Competitors Peer median
Other Investing Activities for CTKB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$794.7M +3497.3%—30.7%
BRKRBruker CorporationLTM Jun 2026$27.4M +13600.0%—0.8%
LABStandard BioTools Inc.LTM Mar 2026$18.6M -39.0%-61.0%21.6%
TXG10x Genomics, Inc.LTM Jun 2026$7.25M -92.6%—1.2%
AAgilent Technologies, Inc.LTM Jul 2026$1M -83.3%+267.8%0.0%
CTKBCytek Biosciences, Inc.LTM Mar 2026$87K +102.3%-3.7%0.0%
Peer median (excluding CTKB) $1M-39.0%+103.4%1.2%

Competitors are the stored peer set for CTKB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income3.03M2.48M(12.15M)(6.02M)(66.54M)
Depreciation & Amortization1.24M5.66M9.23M10.49M11.98M
Deferred Income Tax000(2.89M)33.56M
Stock-Based Compensation6.59M16.6M22.05M26.85M24.59M
Change in Working Capital(8.65M)(39.93M)(10.51M)7.71M(4.79M)
Accounts Receivables(12.37M)(19.74M)(7.33M)(5.43M)368K
Inventory(7.07M)(17.65M)4.29M14.76M(5.24M)
Accounts Payables(256K)1.86M(1.78M)2.58M448K
Other Working Capital11.05M(4.39M)(5.68M)(4.2M)(366K)
Other Non-Cash Items2.42M2.96M(3.34M)(10.77M)(3.47M)
Operating Cash Flow4.63M(12.23M)5.28M25.38M(4.69M)
Capital Expenditures(4.36M)(9.87M)(4.83M)(3.53M)(4.08M)
Acquisitions (Net)(16.63M)0(45.13M)(471K)252K
Purchases of Investments0(46.04M)(175.94M)(274.06M)(278.16M)
Sales of Investments00132M195M292.21M
Other Investing Activities0(120K)(179K)84K(107K)
Investing Cash Flow(20.99M)(55.91M)(93.89M)(82.97M)10.12M
Debt Repayment(2.77M)2.93M(565K)3.62M837K
Common Stock Issued215.69M2.79M001.47M
Common Stock Repurchased00(44.15M)(21.61M)(15.07M)
Dividends Paid00000
Other Financing Activities642K(209K)2.9M2.17M(669K)
Financing Cash Flow213.56M5.51M(41.81M)(15.82M)(13.43M)
Effect of Forex Changes1.3M(2.49M)(1.45M)4.53M109K
Net Change in Cash198.5M(65.12M)(131.87M)(68.89M)(7.89M)
Free Cash Flow266K(22.1M)454K21.85M(8.77M)

Cytek Biosciences, Inc.

NASDAQ:CTKB

Intrinsic Alpha fair value

Locked

Current Price

$5.92

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.